학술논문
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
Document Type
Article
Author
Source
In The Lancet HIV June 2020 7(6):e401-e409
Subject
Language
ISSN
2352-3018